Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, Eur Respir J, vol.23, pp.932-946, 2004. ,
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary, Am J Respir Crit Care Med, vol.187, pp.347-365, 2013. ,
Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance, BMJ, vol.340, p.3134, 2010. ,
Estimation of cigarette smoking-attributable morbidity in the United States, JAMA Intern Med, vol.174, pp.1922-1928, 2014. ,
Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement, Int J Chron Obstruct Pulmon Dis, vol.7, pp.697-709, 2012. ,
Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status, Am J Respir Crit Care Med, vol.167, pp.544-549, 2003. ,
Quantitative assessment of the airway wall using computed tomography and optical coherence tomography, Proc Am Thorac Soc, vol.6, pp.439-443, 2009. ,
Thin-section CT in obstructive pulmonary disease: discriminatory value, Radiology, vol.223, pp.812-819, 2002. ,
New and current clinical imaging techniques to study chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.180, pp.588-597, 2009. ,
A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation, COPD, vol.9, pp.151-159, 2012. ,
Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression, Nat Med, vol.18, pp.1711-1715, 2012. ,
Accuracy of low-dose computed tomography (CT) for detecting and characterizing the most common CT-patterns of pulmonary disease, Eur J Radiol, vol.82, pp.142-150, 2013. ,
Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers, Am J Respir Crit Care Med, vol.188, pp.1083-1090, 2013. ,
Using pulmonary imaging to move COPD beyond FEV1, Am J Respir Crit Care Med, vol.190, pp.135-144, 2014. ,
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers, Eur Respir J, vol.20, pp.1117-1122, 2002. ,
Underestimation of airflow obstruction among young adults using FEV1/FVC < 70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes, Thorax, vol.63, pp.1040-1045, 2008. ,
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction, Thorax, vol.69, pp.409-414, 2014. ,
High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden -a challenge for public health, BMC Public Health, vol.13, pp.670-678, 2013. ,
Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD, Thorax, vol.63, pp.768-774, 2008. ,
Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, vol.148, pp.529-534, 2008. ,
Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group, Ann Intern Med, vol.127, pp.1072-1079, 1997. ,
Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD, Chest, vol.115, pp.635-641, 1999. ,
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial, BMJ, vol.320, pp.1297-1303, 2000. ,
Acute exacerbation of COPD: factors associated with poor treatment outcome, Chest, vol.117, pp.662-671, 2000. ,
Prognosis in chronic obstructive pulmonary disease, Am Rev Respir Dis, vol.133, pp.14-20, 1986. ,
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea, Am J Respir Crit Care Med, vol.185, pp.435-452, 2012. ,
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.157, pp.1791-1797, 1998. ,
Prognostic value of nutritional status in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.160, pp.1856-1861, 1999. ,
Patient-reported dyspnea in COPD reliability and association with stage of disease, Chest, vol.136, pp.1473-1479, 2009. ,
Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD, Chest, vol.121, pp.1434-1440, 2002. ,
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease, N Engl J Med, vol.350, pp.1005-1012, 2004. ,
The modified BODE index: validation with mortality in COPD, Eur Respir J, vol.32, pp.1269-1274, 2008. ,
Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients, Respir Med, vol.103, pp.692-699, 2009. ,
Multicomponent indices to predict survival in COPD: the COCOMICS study, Eur Respir J, vol.42, pp.323-332, 2013. ,
Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.185, pp.1065-1072, 2012. ,
Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index, Lancet, vol.374, pp.704-711, 2009. ,
Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE index, Am J Respir Crit Care Med, vol.180, pp.1189-1195, 2009. ,
Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.186, pp.155-161, 2012. ,
Short-and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index, Chest, vol.145, pp.972-980, 2014. ,
Lungs, bone marrow, and adipose tissue. A network approach to the pathobiology of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.188, pp.1396-1406, 2013. ,
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease, Thorax, vol.57, pp.847-852, 2002. ,
Changes in forced expiratory volume in 1 second over time in COPD, N Engl J Med, vol.365, pp.1184-1192, 2011. ,
The human phenome project, Nat Genet, vol.34, pp.15-21, 2003. ,
Chronic obstructive pulmonary disease phenotypes: the future of COPD, Am J Respir Crit Care Med, vol.182, pp.598-604, 2010. ,
Ageing and multimorbidity, Eur Respir J, vol.44, p.557, 2014. ,
Network medicine, multimorbidity and the lung in the elderly, Eur Respir J, vol.44, pp.775-788, 2014. ,
Ageing and the epidemiology of multimorbidity, Eur Respir J, vol.44, pp.1055-1068, 2014. ,
The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD, Chest, vol.141, pp.851-857, 2012. ,
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD, Eur Respir J, vol.32, pp.962-969, 2008. ,
Lung cancer in patients with chronic obstructive pulmonary diseaseincidence and predicting factors, Am J Respir Crit Care Med, vol.184, pp.913-919, 2011. ,
Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the Pittsburgh lung screening study, J Thorac Oncol, vol.6, pp.1200-1205, 2011. ,
Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.187, pp.728-735, 2013. ,
Increased risk of myocardial infarction and stroke following exacerbation of COPD, Chest, vol.137, pp.1091-1097, 2010. ,
Prediction of acute respiratory disease in current and former smokers with and without COPD, Chest, vol.146, pp.941-950, 2014. ,
Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study, Thorax, vol.69, pp.709-717, 2014. ,
Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome, Am J Respir Crit Care Med, vol.182, pp.325-331, 2010. ,
Global effects of smoking, of quitting, and of taxing tobacco, N Engl J Med, vol.370, pp.60-68, 2014. ,
Smoking and lung function of Lung Health Study participants after 11 years, Am J Respir Crit Care Med, vol.166, pp.675-679, 2002. ,
Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial, BMJ, vol.336, pp.598-600, 2008. ,
Smokers with airway obstruction are more likely to quit smoking, Thorax, vol.61, pp.869-873, 2006. ,
The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD, Scand J Prim Health Care, vol.24, pp.133-139, 2006. ,
Efficacy of confronting smokers with airflow limitation for smoking cessation, Eur Respir J, vol.33, pp.754-762, 2009. ,
Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial, Lancet, vol.357, pp.1571-1575, 2001. ,
Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial, Chest, vol.139, pp.591-599, 2011. ,
Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support, Chest, vol.130, pp.334-342, 2006. ,
The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review, Respir Med, vol.98, pp.805-815, 2004. ,
Depression in the patient with COPD, Int J Chron Obstruct Pulmon Dis, vol.1, pp.61-64, 2006. ,
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial, Circulation, vol.121, pp.221-229, 2010. ,
Effect of varying levels of disease management on smoking cessation: a randomized trial, Ann Intern Med, vol.150, pp.437-446, 2009. ,
Treating tobacco use and dependence: 2008 update. Clinical Practice Guidelines, Department of Health and Human Services, 2008. ,
Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients, Psychopharmacology (Berl), vol.119, pp.193-204, 1995. ,
Electronic nicotine delivery systems: a research agenda, Tob Control, vol.20, pp.243-248, 2011. ,
Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy, Addiction, vol.106, pp.2017-2028, 2011. ,
Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey, Drug Alcohol Rev, vol.32, pp.133-140, 2013. ,
Electronic cigarettes: a short review, Respiration, vol.86, pp.433-438, 2013. ,
Electronic cigarettes. A position statement of the forum of international respiratory societies, Am J Respir Crit Care Med, vol.190, pp.611-618, 2014. ,
The effect of smoking cessation and modification on lung function, Am Rev Respir Dis, vol.114, pp.115-122, 1976. ,
Harm reduction -a treatment approach for resistant smokers with tobacco-related symptoms, Respiration, vol.69, pp.452-455, 2002. ,
Short-term smoking reduction is associated with reduction in measures of lower respiratory tract inflammation in heavy smokers, Eur Respir J, vol.3, pp.752-759, 1990. ,
Smoking reduction and the rate of decline in FEV1: results from the Lung Health Study, Eur Respir J, vol.25, pp.1011-1017, 2005. ,
Does smoking reduction increase future cessation and decrease disease risk? A qualitative review, Nicotine Tob Res, vol.8, pp.739-749, 2006. ,
Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review, Arch Intern Med, vol.167, pp.221-228, 2007. ,
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease, N Engl J Med, vol.356, pp.775-789, 2007. ,
A 4-year trial of tiotropium in chronic obstructive pulmonary disease, N Engl J Med, vol.359, pp.1543-1554, 2008. ,
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study, Respir Res, vol.10, p.59, 2009. ,
Tiotropium might improve survival in subjects with COPD at high risk of mortality, Respir Res, vol.15, p.64, 2014. ,
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study, Am J Respir Crit Care Med, vol.178, pp.332-338, 2008. ,
Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial, Lancet, vol.374, pp.1171-1178, 2009. ,
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.9, p.9157, 2012. ,
Effect of ADRB2 polymorphism on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial, Lancet Respir Med, vol.2, pp.44-53, 2014. ,
Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study, Lancet Respir Med, vol.1, pp.524-533, 2013. ,
Reported pneumonia in patients with COPD: findings from the INSPIRE study, Chest, vol.139, pp.505-512, 2011. ,
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results, Eur Respir J, vol.34, pp.641-647, 2009. ,
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide, Am J Respir Crit Care Med, vol.177, pp.19-26, 2008. ,
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial, Ann Intern Med, vol.146, pp.545-555, 2007. ,
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study, Lancet Respir Med, vol.1, pp.199-209, 2013. ,
Withdrawal of inhaled glucocorticoids and exacerbations of COPD, N Engl J Med, vol.371, pp.1285-1294, 2014. ,
UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation, Thorax, vol.61, pp.837-842, 2006. ,
Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease, Arch Intern Med, vol.170, pp.880-887, 2010. ,
Systemic manifestations of COPD, Chest, vol.139, pp.165-173, 2011. ,
statement: key concepts and advances in pulmonary rehabilitation, Am J Respir Crit Care Med, vol.188, pp.13-64, 2013. ,
Home-based pulmonary rehabilitation in chronic obstructive pulmonary disease patients, Curr Opin Pulm Med, vol.16, pp.134-143, 2010. ,
Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial, Ann Intern Med, vol.149, pp.869-878, 2008. ,
Short-and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial, Thorax, vol.65, pp.7-13, 2010. ,
Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial, J Am Med Dir Assoc, vol.11, pp.179-187, 2010. ,
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.10, p.5305, 2011. ,
Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD, Chest, vol.127, pp.809-817, 2005. ,
, Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party, Lancet, vol.1, pp.681-686, 1981.
, Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group, Ann Intern Med, vol.93, pp.391-398, 1980.
Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia, Thorax, vol.52, pp.674-679, 1997. ,
Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease, N Engl J Med, vol.333, pp.817-822, 1995. ,
Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease, Lancet, vol.341, pp.1555-1557, 1993. ,
Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure, Am J Respir Crit Care Med, vol.151, pp.1799-1806, 1995. ,
Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial, Lancet, vol.355, pp.1931-1935, 2000. ,
Non-invasive ventilation in acute respiratory failure, Lancet, vol.374, pp.250-259, 2009. ,
Noninvasive positive pressure ventilation in subjects with stable COPD: a randomized trial, Int J Chron Obstruct Pulmon Dis, vol.8, pp.581-589, 2013. ,
Bénéfices de la ventilation non invasive a domicile au décours d'une insuffisance respiratoire aigue hypercapnique chez les patients BPCO. Etude contrôlée randomisée multicentrique. Etude Non Invasive Ventilation in Obstructive Lung Disease (Nivold) [A multi-centre randomized controlled trial of domiciliary non-invasive ventilation vs long-term oxygen therapy in survivors of acute hypercapnic respiratory failure due to COPD. Non-invasive ventilation ,
, Rev Mal Respir, vol.29, pp.1141-1148, 2012.
The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients, Eur Respir J, vol.20, pp.529-538, 2002. ,
Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomized, controlled, parallel-group study, Thorax, vol.69, pp.826-834, 2014. ,
Nocturnal noninvasive positive pressure ventilation in stable COPD: a systematic review and individual patient data meta-analysis, Respir Med, vol.108, pp.329-337, 2014. ,
Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial, Lancet Respir Med, vol.2, pp.698-705, 2014. ,